2.Safety and durable patency of tunneled hemodialysis catheter inserted without fluoroscopy
Do Hyoung KIM ; Sojung YOUN ; Tae Hyun BAN ; Bum Soon CHOI ; Byung Soo KIM ; Cheol Whee PARK ; Chul Woo YANG ; Hoon Suk PARK
Kidney Research and Clinical Practice 2023;42(6):723-730
		                        		
		                        			
		                        			 A tunneled hemodialysis (HD) catheter is preferred due to its lower incidence of infection and malfunction than non-tunneled ones. For safer insertion, fluoroscopic guidance is desirable. However, if the patient is unstable, transfer to the fluoroscopy may be impossible or inappropriate. Methods: From June 2019 to September 2022, 81 tunneled HD catheter insertion cases performed under ultrasound guidance without fluoroscopy and 474 cases with fluoroscopy in our institutional HD catheter cohort were retrospectively compared. Results: Immediate complications, later catheter-associated problems, including infections and catheter dysfunction, were comparable between the two groups (p = 0.20 and p = 0.37, respectively). The patency of tunneled catheters inserted without fluoroscopy was comparable to the patency of tunneled catheters inserted with fluoroscopic guidance (p = 0.90). Conclusion: Tunneled HD catheter insertion without fluoroscopy can be performed safely and has durable patency compared to the insertion with fluoroscopy. Therefore, this method can be considered for the selected unstable patients (e.g., ventilator care) in the intensive care unit. 
		                        		
		                        		
		                        		
		                        	
3.Crohn’s Disease Identified as Granulomatous Tubulointerstitial Nephritis
Jung Suk HAN ; Bum Soon CHOI ; Cheol Whee PARK ; Yeong Jin CHOI ; Chul Woo YANG ; Han Hee LEE ; Tae Hyun BAN
Korean Journal of Medicine 2022;97(3):186-190
		                        		
		                        			
		                        			 Crohn’s disease is usually diagnosed according to intestinal symptoms, but extra-intestinal manifestations are important in approximately one-third of cases. Although several extra-intestinal symptoms associated with various organs have been reported, renal involvement is uncommon in patients with Crohn’s disease. Tubulointerstitial nephritis in a patient with Crohn’s disease is usually caused by infection, sarcoidosis, or medications. However, primary tubulointerstitial nephritis caused by Crohn’s disease alone is extremely rare. A 19-year-old male patient was referred to our hospital because of an increase in serum creatinine level. He underwent a kidney biopsy with renal insufficiency. Renal histological findings revealed granulomatous tubulointerstitial nephritis. Thereafter, a colonoscopy was performed with suspicion of Crohn’s disease. Ultimately, he was diagnosed with granulomatous tubulointerstitial nephritis based on Crohn’s disease. The patient had improved gastrointestinal symptoms after the last treatment. This case report presents a rare case of primary tubulointerstitial nephritis caused by Crohn’s disease. 
		                        		
		                        		
		                        		
		                        	
4.Fabry disease exacerbates renal interstitial fibrosis after unilateral ureteral obstruction via impaired autophagy and enhanced apoptosis
Sungjin CHUNG ; Mina SON ; Yura CHAE ; Songhee OH ; Eun Sil KOH ; Yong Kyun KIM ; Seok Joon SHIN ; Cheol Whee PARK ; Sung-Chul JUNG ; Ho-Shik KIM
Kidney Research and Clinical Practice 2021;40(2):208-219
		                        		
		                        			Background:
		                        			Fabry disease is a rare X-linked genetic lysosomal disorder caused by mutations in the GLA gene encoding alpha-galactosidase A. Despite some data showing that profibrotic and proinflammatory cytokines and oxidative stress could be involved in Fabry disease-related renal injury, the pathogenic link between metabolic derangement within cells and renal injury remains unclear. 
		                        		
		                        			Methods:
		                        			Renal fibrosis was triggered by unilateral ureteral obstruction (UUO) in mice with Fabry disease to investigate the pathogenic mechanism leading to fibrosis in diseased kidneys. 
		                        		
		                        			Results:
		                        			Compared to kidneys of wild-type mice, lamellar inclusion bodies were recognized in proximal tubules of mice with Fabry disease. Sirius red and trichrome staining revealed significantly increased fibrosis in all UUO kidneys, though it was more prominent in obstructed Fabry kidneys. Renal messenger RNA levels of inflammatory cytokines and profibrotic factors were increased in all UUO kidneys compared to sham-operated kidneys but were not significantly different between UUO control and UUO Fabry mice. Protein levels of Nox2, Nox4, NQO1, catalase, SOD1, SOD2, and Nrf2 were not significantly different between UUO control and UUO Fabry kidneys, while the protein contents of LC3-II and LC3-I and expression of Beclin1 were significantly decreased in UUO kidneys of Fabry disease mouse models compared with wild-type mice. Notably, TUNEL-positive cells were elevated in obstructed kidneys of Fabry disease mice compared to wild-type control and UUO mice. 
		                        		
		                        			Conclusion
		                        			These findings suggest that impaired autophagy and enhanced apoptosis are probable mechanisms involved in enhanced renal fibrosis under the stimulus of UUO in Fabry disease.
		                        		
		                        		
		                        		
		                        	
5.Fabry disease exacerbates renal interstitial fibrosis after unilateral ureteral obstruction via impaired autophagy and enhanced apoptosis
Sungjin CHUNG ; Mina SON ; Yura CHAE ; Songhee OH ; Eun Sil KOH ; Yong Kyun KIM ; Seok Joon SHIN ; Cheol Whee PARK ; Sung-Chul JUNG ; Ho-Shik KIM
Kidney Research and Clinical Practice 2021;40(2):208-219
		                        		
		                        			Background:
		                        			Fabry disease is a rare X-linked genetic lysosomal disorder caused by mutations in the GLA gene encoding alpha-galactosidase A. Despite some data showing that profibrotic and proinflammatory cytokines and oxidative stress could be involved in Fabry disease-related renal injury, the pathogenic link between metabolic derangement within cells and renal injury remains unclear. 
		                        		
		                        			Methods:
		                        			Renal fibrosis was triggered by unilateral ureteral obstruction (UUO) in mice with Fabry disease to investigate the pathogenic mechanism leading to fibrosis in diseased kidneys. 
		                        		
		                        			Results:
		                        			Compared to kidneys of wild-type mice, lamellar inclusion bodies were recognized in proximal tubules of mice with Fabry disease. Sirius red and trichrome staining revealed significantly increased fibrosis in all UUO kidneys, though it was more prominent in obstructed Fabry kidneys. Renal messenger RNA levels of inflammatory cytokines and profibrotic factors were increased in all UUO kidneys compared to sham-operated kidneys but were not significantly different between UUO control and UUO Fabry mice. Protein levels of Nox2, Nox4, NQO1, catalase, SOD1, SOD2, and Nrf2 were not significantly different between UUO control and UUO Fabry kidneys, while the protein contents of LC3-II and LC3-I and expression of Beclin1 were significantly decreased in UUO kidneys of Fabry disease mouse models compared with wild-type mice. Notably, TUNEL-positive cells were elevated in obstructed kidneys of Fabry disease mice compared to wild-type control and UUO mice. 
		                        		
		                        			Conclusion
		                        			These findings suggest that impaired autophagy and enhanced apoptosis are probable mechanisms involved in enhanced renal fibrosis under the stimulus of UUO in Fabry disease.
		                        		
		                        		
		                        		
		                        	
6.Mortality prediction of serum neutrophil gelatinase-associated lipocalin in patients requiring continuous renal replacement therapy
Yohan PARK ; Tae Hyun BAN ; Hyung Duk KIM ; Eun Jeong KO ; Jongmin LEE ; Seok Chan KIM ; Cheol Whee PARK ; Chul Woo YANG ; Yong-Soo KIM ; Byung Ha CHUNG
The Korean Journal of Internal Medicine 2021;36(2):392-400
		                        		
		                        			 Background/Aims:
		                        			We investigated whether serum neutrophil gelatinase-associated lipocalin (NGAL) can predict mortality in patients with acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT). 
		                        		
		                        			Methods:
		                        			This study enrolled 169 patients who underwent serum NGAL testing at CRRT initiation from June 2017 to January 2019. The predictive power of serum NGAL level for 28-day mortality was compared to the Acute Physiology and Chronic Health Evaluation-II (APACHE-II) score and Sequential Organ Failure Assessment (SOFA) score via area under the receiver operating characteristic curve (AuROC) value. 
		                        		
		                        			Results:
		                        			There were 55 survivors and 114 non-survivors at 28 days post-CRRT initiation. Median serum NGAL level was significantly higher in the non-survivor group than in the survivor group (743.0 ng/mL vs. 504.0 ng/mL, p = 0.003). The AuROC value of serum NGAL level was 0.640, which was lower than APACHEII score and SOFA score values (0.767 and 0.715, respectively). However, in the low APACHE-II score group (< 27.5), AuROC value of serum NGAL was significantly increased (0.698), and it was an independent risk factor for 28 day-mortality (hazard ratio, 2.405; 95% confidence interval, 1.209 to 4.783; p = 0.012). 
		                        		
		                        			Conclusions
		                        			In patients with AKI requiring CRRT, serum NGAL levels may be useful for predicting short-term mortality in those with low APACHE-II scores. 
		                        		
		                        		
		                        		
		                        	
7.Low parathyroid hormone level predicts infection-related mortality in incident dialysis patients: a prospective cohort study
Yu Ah HONG ; Jeong Ho KIM ; Yong Kyun KIM ; Yoon Kyung CHANG ; Cheol Whee PARK ; Suk Young KIM ; Yon Su KIM ; Shin-Wook KANG ; Nam-Ho KIM ; Yong-Lim KIM ; Chul Woo YANG
The Korean Journal of Internal Medicine 2020;35(1):160-170
		                        		
		                        			 Background/Aims:
		                        			Parathyroid hormone (PTH) is an important factor influencing immunologic dysfunction, but the effect of PTH level on infection-related outcomes remains unclear in incident dialysis. 
		                        		
		                        			Methods:
		                        			We evaluated a multicenter prospective cohort study of 1,771 incident dialysis patients (1,260 hemodialysis and 511 peritoneal dialysis) in Korea. Patients were divided into three groups based on serum intact PTH (iPTH) level. The primary outcomes were all-cause and infection-related mortality and multivariate Cox regression analysis was performed to evaluate the role of iPTH in all-cause and infection-related mortality. 
		                        		
		                        			Results:
		                        			During the follow-up period of 27.3 months, 175 patients (9.9%) died, and infection-related death represented 20% of all-cause mortality. Both all-cause mortality and infection-related mortality rates (p < 0.001 and p = 0.003, by logrank) were markedly higher in patients with serum iPTH < 150 pg/mL than in the other groups. Multivariate Cox regression analysis revealed that patients with serum iPTH < 150 pg/mL remained at higher risk for infection-related mortality than patients in the target range of 150 ≤ iPTH < 300 pg/mL, after adjusting for confounding variables (hazard ratio [HR], 2.52; 95% confidence interval, 1.06 to 5.99; p = 0.04). The HR of infection-related mortality in patients with serum iPTH < 150 pg/mL was significantly higher in patients with low serum phosphorus, low Ca × P product, low serum alkaline phosphatase and those older than 65 years. 
		                        		
		                        			Conclusions
		                        			Low serum iPTH level is an independent predictor of infection-related mortality in incident dialysis patients. 
		                        		
		                        		
		                        		
		                        	
8.Recurrent Severe Hyponatremia in a Patient with Sjögren’s Syndrome
Hyung Duk KIM ; Jennifer LEE ; Byung Ha CHUNG ; Chul Woo YANG ; Yong-Soo KIM ; Cheol Whee PARK
Electrolytes & Blood Pressure 2020;18(1):19-22
		                        		
		                        			
		                        			Sjögren's syndrome (SS) is an autoimmune disease that presents with exocrine gland dysfunction. Renal involvement is common in SS and often results in tubulointerstitial nephritis, renal tubular acidosis, and Fanconi’s syndrome. Electrolyte imbalances are commonly the first symptom of renal involvement of SS. The most common feature of dysnatremia in SS is hypernatremia with diabetes insipidus. However, cases of hyponatremia with syndrome of inappropriate antidiuretic hormone secretion (SIADH) are rarely reported in patients with SS. Herein, we report a case of recurrent severe SIADH in a patient with SS.
		                        		
		                        		
		                        		
		                        	
9.Recurrent Severe Hyponatremia in a Patient with Sjögren’s Syndrome
Hyung Duk KIM ; Jennifer LEE ; Byung Ha CHUNG ; Chul Woo YANG ; Yong-Soo KIM ; Cheol Whee PARK
Electrolytes & Blood Pressure 2020;18(1):19-22
		                        		
		                        			
		                        			Sjögren's syndrome (SS) is an autoimmune disease that presents with exocrine gland dysfunction. Renal involvement is common in SS and often results in tubulointerstitial nephritis, renal tubular acidosis, and Fanconi’s syndrome. Electrolyte imbalances are commonly the first symptom of renal involvement of SS. The most common feature of dysnatremia in SS is hypernatremia with diabetes insipidus. However, cases of hyponatremia with syndrome of inappropriate antidiuretic hormone secretion (SIADH) are rarely reported in patients with SS. Herein, we report a case of recurrent severe SIADH in a patient with SS.
		                        		
		                        		
		                        		
		                        	
10.Clinical outcomes and effects of treatment in older patients with idiopathic membranous nephropathy
Yaeni KIM ; Hye Eun YOON ; Byung Ha CHUNG ; Bum Soon CHOI ; Cheol Whee PARK ; Chul Woo YANG ; Yong Soo KIM ; Yu Ah HONG ; Suk Young KIM ; Yoon Kyung CHANG ; Hyeon Seok HWANG
The Korean Journal of Internal Medicine 2019;34(5):1091-1099
		                        		
		                        			 BACKGROUND/AIMS:
		                        			Membranous nephropathy (MN) is the most common primary glomerular disease diagnosed in older patients. Few reports describe the clinical outcomes in older patients with idiopathic MN.
		                        		
		                        			METHODS:
		                        			The outcomes of 135 patients with histologically proven MN were analyzed. ‘Older’ was defined as 60 years of age or older at the time of the renal biopsy. The rates of complete remission (CR), progression to end-stage renal disease (ESRD) and infection were compared between older and younger patients.
		                        		
		                        			RESULTS:
		                        			The cumulative event rate for achieving CR was inferior (p = 0.012) and that for requiring renal replacement was higher (p = 0.015) in older patients, and they had a greater risk of infection (p = 0.005). Older age was a significant predictor of a lower rate of CR (adjusted odds ratio [OR], 0.51; 95% confidence interval [CI], 0.26 to 0.98), and was a robust predictor of infection (adjusted OR, 5.27; 95% CI, 1.31 to 21.20). Conservative treatment was associated with a lower remission rate (p = 0.036) and corticosteroid treatment was less effective in achieving CR (p = 0.014), in preventing progression to ESRD (p = 0.013) and in reducing infection (p = 0.033) in older patients. Cyclosporine treatment had similar clinical outcomes with regard to CR, ESRD progression, and infection in older patients.
		                        		
		                        			CONCLUSIONS
		                        			Older age was independently associated with inferior rates of CR and greater risk of infection. Treatment modalities affected the outcomes of older patients differently in that cyclosporine treatment is predicted to be more useful than corticosteroids. 
		                        		
		                        		
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail